Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: A systematic review and network meta-analysis

Joint Bone Spine

Volumn 81, Issue 4, 2014, Pages 337-341

  Hazlewood, Glen S ^a   Metzler, Claudia ^b   Tomlinson, George A ^c   Gross, Wolfgang L ^b   Feldman, Brian M ^d   Guillevin, Loic ^e   Pagnoux, Christian ^f  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e Institut Cochin   (France)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti neutrophil cytoplasm antibody associated vasculitis; Azathioprine; Leflunomide; Meta analysis; Methotrexate; Mycophenolic acid

Indexed keywords

AZATHIOPRINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID;

ANCA ASSOCIATED VASCULITIS; ARTICLE; DRUG DOSE ESCALATION; DRUG EFFICACY; FOLLOW UP; GRANULOMATOSIS; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; RELAPSE; REMISSION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; CLINICAL PRACTICE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; WEGENER GRANULOMATOSIS;

ANTI-NEUTROPHIL CYTOPLASM ANTIBODY-ASSOCIATED VASCULITIS; AZATHIOPRINE; LEFLUNOMIDE; META-ANALYSIS; METHOTREXATE; MYCOPHENOLIC ACID;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AZATHIOPRINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84904116116     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.11.006     Document Type: Article

References (12)

1. Mukhtyar C., Guillevin L., Cid M.C., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68:310-317.
2. Pagnoux C., Mahr A., Hamidou M.A., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359:2790-2803.
3. Hiemstra T.F., Walsh M., Mahr A., et al. Mycophenolate mofetil vs. azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 2010, 304:2381-2388.
4. Holle J.U., Gross W.L., Latza U., et al. Improved outcome in 445patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011, 63:257-266.
5. Metzler C., Miehle N., Manger K., et al. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 2007, 46:1087-1091.
6. Mukhtyar C., Flossmann O., Hellmich B., et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum Dis 2008, 67:1004-1010.
7. Higgins J.P., Altman D.G., Gotzsche P.C., et al. The Cochrane Collaaaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
8. Woods B.S., Hawkins N., Scott D.A. Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol 2010, 10:54.
9. Bassler D., Briel M., Montori V.M., et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010, 303:1180-1187.
10. Bosch X., Guilabert A., Espinosa G., et al. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007, 298:655-669.
11. Dias S., Welton N.J., Caldwell D.M., et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med 2010, 29:932-944.
12. Walsh M., Merkel P.A., Mahr A., et al. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken) 2010, 62:1166-1173.